HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Ami informs that PMDA Japan has issued Inspection Result Report declaring the Sachin facility as a Good Manufacturing Practices (GMP) compliant.
USFDA has determined that the inspection classification of this facility is "No Action Indicated" (NAI) with zero 483 observation
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
